MIAMI – La Fundación para las terapias del síndrome de Angelman (FAST) anunció hoy una donación de 5 millones USD para establecer un nuevo proyecto
FAST establece el Consorcio de Atención de Emergencia para ayudar a más del 90% de individuos con el Síndrome de Angelman que han reportado tener epilepsi
How was FAST UK born? “FAST (Foundation for Angelman Syndrome Therapeutics) UK was born after our eldest daughter Amelia was diagnosed with Angelman syndro
AS & Artificial Intelligence in the News, FAST and Lixte Collaborate to support preclinical study Dr. Jiang seeking participants, Upcoming concert by Joe
December 6th 2008 not only marked the official launch of the new foundation, Foundation for Angelman Syndrome Therapeutics(“FAST”), but also became a nig
FAST is proud to announce the newest addition to its global family: FAST France. Charlotte Prestat and Anthony Moisan, the founders of FAST France, have thre
The Global Angelman Syndrome Registry (Registry) had some downtime this week while the platform was moved to the Division of Researc
GeneTx Biotherapeutics has announced it has received IRB approval from Rush University Medical Center in Chicago, IL to begin the “KIK-AS” (Knock
Two press releases were issued recently with one announcing an Exclusive Option Agreement between GeneTx Biotherapeutics, LLC (“GeneTx”) and U
Downers Grove, Ill., March 27, 2018 – The U.S. Food and Drug Administration has granted orphan-drug designation to GeneTx Biotherapeutics LLC’s GTX-101 f
